CVE-2024-41668 - CVE House
Back to Database
Status published High CVE-2024-41668

cBioPortal Proxy Endpoint Vulnerabliity

Vulnerability Description

The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable `/proxy` endpoint entirely via, for example, nginx.

Impact Analysis

Refer to official advisory for detailed impact metrics.

Remediation

Ensure systems are updated to the latest vendor-supplied patch levels.

THREAT MONITOR

Am I Vulnerable?

Launch our assessment wizard to check if your infrastructure is exposed to • CVE-2024-41668

Credits & Attribution

No credits recorded in the NVD database.

Affected Vendor

Affected Software

cbioportal
Vulnerable Versions:
< 6.0.12

Timeline

Official Publish: July 23rd, 2024
Last Modified: August 2nd, 2024
Added to House: July 22nd, 2026

CVSS Vectors

V3: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:L

Weaknesses (CWE)